$EVFM 8-K SEC Filings

Filed On	Filing
15 Oct 2026	8-K: Entry into a Material Definitive Agreement This Fifth Amendment to Securities Purchase Agreement (this “Fifth Amendment”) is entered into as of October 9, 2026 (the “Fifth Amendment Effective Date”) by and among Evofem Biosciences, Inc., a Delaware corporation (the “Company”), Ad...
23 Sep 2026	8-K: Entry into a Material Definitive Agreement [***] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.
20 Jul 2026	8-K: Regulation FD Disclosure
14 Jul 2026	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation
18 May 2026	8-K: Results of Operations and Financial Condition
30 Apr 2026	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
16 Apr 2026	8-K: Entry into a Material Definitive Agreement
19 Mar 2026	8-K: Termination of a Material Definitive Agreement
11 Mar 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
12 Jan 2026	8-K: Regulation FD Disclosure
26 Nov 2025	8-K: Amendments to Articles/Bylaws; Change in Fiscal Year; Submission of Matters to a Vote of Security Holders
13 Nov 2025	8-K: Results of Operations and Financial Condition
20 Oct 2025	8-K: Termination of a Material Definitive Agreement; Submission of Matters to a Vote of Security Holders +1 more
17 Oct 2025	8-K: Entry into a Material Definitive Agreement
26 Aug 2025	8-K: Entry into a Material Definitive Agreement; Material Modification to Rights of Security Holders +1 more
14 Aug 2025	8-K: Results of Operations and Financial Condition
02 Jul 2025	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities
22 May 2025	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
15 May 2025	8-K: Results of Operations and Financial Condition
08 May 2025	8-K: Entry into a Material Definitive Agreement

Comments